What is Steglatro?
Steglatro is an oral prescription medication used to improve blood sugar control in adults with type 2 diabetes. It contains the active ingredient ertugliflozin. This drug belongs to a class of medicines known as SGLT2 inhibitors. It is designed to be used together with a healthy diet and regular exercise. Steglatro helps manage the key aspects of diabetes care. It a modern treatment option for long-term glycemic management. This medication helps protect vital organs from the damage high blood sugar can cause over time.
How does Steglatro work?
Steglatro works by blocking a protein in the kidneys called sodium-glucose cotransporter 2 (SGLT2). This protein is responsible for reabsorbing sugar from the urine back into the bloodstream. By inhibiting SGLT2, Steglatro causes more sugar to be removed from the body through the urine. This process effectively lowers blood glucose levels. Additionally, it affects how the kidneys handle salt and water. This can reduce the workload on the heart. It also lowers pressure within the kidney’s filtering units, providing protective benefits for the heart and kidneys.
Who is Steglatro for?
Steglatro is primarily for adults diagnosed with type 2 diabetes mellitus. It is prescribed to patients who need help managing their blood sugar levels. Your doctor may suggest it as part of a broader treatment plan. This plan should include diet and physical activity. It is also suitable for patients with type 2 diabetes who are at risk for cardiovascular events. This includes reducing the risk of heart failure. It can also be used for those with chronic kidney disease to slow its progression.
Dosage and administration
Steglatro is taken as an oral tablet, typically once a day in the morning. It can be taken with or without food. The exact dosage is determined by your healthcare provider. They will consider your medical condition, kidney function, and other medications you might be taking. It is very important to follow your doctor’s instructions carefully. Do not change your dose without consulting them first. Always read the patient information leaflet that comes with your medicine for full details on how to take it.
Side effects
Steglatro may cause side effects in some people, though not everyone will experience them. The most common side effects include vaginal yeast infections in women and yeast infections of the penis in men. Other possible effects are urinary tract infections and changes in urination. Dehydration is also a risk, so it is important to drink enough fluids. In rare cases, a serious condition called ketoacidosis can occur. Seek medical attention if you experience nausea, vomiting, stomach pain, or trouble breathing. Always tell your doctor about any side effects.
Why buy from IsraelPharm?
IsraelPharm offers a smart and affordable way to get your prescription medications like Steglatro. We provide authentic, brand-name drugs sourced from licensed global pharmacies. This allows us to offer significant savings compared to typical US prices. Our service is convenient and reliable. We ensure your medication is delivered directly to your door. Our customer care team is available to assist you with your order. You can trust IsraelPharm for safe, cost-effective access to the medicines you need to manage your health effectively.
Some patients may experience side effects while taking Steglatro. Common ones include:
- Vaginal yeast infections in women (itching, odor, or discharge).
- Yeast infections of the skin around the penis in men.
- Symptoms of a common cold, like a runny nose or sore throat (nasopharyngitis).
- Urinary tract infections.
If these effects do not resolve or get worse, you should speak with your doctor. This list is not complete. Please read the manufacturer’s patient leaflet and consult a healthcare provider for a full list of side effects.
Steglatro is prescribed to adults for several key purposes:
- To improve glycemic control in type 2 diabetes, along with diet and exercise.
- To reduce the risk of declining kidney function and end-stage kidney disease.
- To lower the risk of heart failure in adults with type 2 diabetes or chronic kidney disease.